quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:15:24·30d
SECFiling
MaxCyte Inc. logo

MaxCyte Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

MXCT· MaxCyte Inc.
Health Care
Original source

Companies

  • MXCT
    MaxCyte Inc.
    Health Care

Recent analyst ratings

  • Aug 11UpdateBTIG Research-
  • Aug 7UpdateWilliam Blair-
  • Jul 22UpdateStephens$6.00
  • Nov 29UpdateCraig Hallum$7.00
  • Oct 15UpdateCowen-
  • Aug 24UpdateWedbush$36.00

Related

  • INSIDER6d
    SEC Form 4 filed by Ahuja Parmeet
  • SEC8d
    SEC Form S-8 filed by MaxCyte Inc.
  • INSIDER13d
    SEC Form 4 filed by Ahuja Parmeet
  • INSIDER13d
    SEC Form 3 filed by new insider Ahuja Parmeet
  • INSIDER23d
    SEC Form 4 filed by Masoud Maher
  • PR23d
    MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • SEC27d
    MaxCyte Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by MaxCyte Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022